These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 7007357)

  • 21. Nomifensine in the treatment of depressed geriatric patients.
    Goldstein SE; Birnbom F; Laliberte R
    J Clin Psychiatry; 1982 Jul; 43(7):287-9. PubMed ID: 7045090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind study of the efficacy and safety of dothiepin hydrochloride in the treatment of major depressive disorder.
    Stratas NE
    J Clin Psychiatry; 1984 Nov; 45(11):466-9. PubMed ID: 6386793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative, multicenter trial between bromocriptine and amitriptyline in the treatment of endogenous depression.
    Theohar C; Fischer-Cornelssen K; Brosch H; Fischer EK; Petrovic D
    Arzneimittelforschung; 1982; 32(7):783-7. PubMed ID: 6751339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the antidepressant effects of a synthetic androgen (mesterolone) and amitriptyline in depressed men.
    Vogel W; Klaiber EL; Broverman DM
    J Clin Psychiatry; 1985 Jan; 46(1):6-8. PubMed ID: 3880735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
    Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J
    Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients.
    Gelenberg AJ; Wojcik JD; Newell C; Lamping DL; Spring B
    J Clin Psychopharmacol; 1985 Feb; 5(1):30-4. PubMed ID: 3882774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amoxapine in the treatment of depression. A clinical evaluation in ambulant patients.
    van Wyk EM; Louw DA
    S Afr Med J; 1982 Jun; 61(24):908-11. PubMed ID: 7046092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of amoxapine, maprotiline, and trazodone in comparison to imipramine and amitriptyline: a review of the literature.
    Kane JM; Lieberman J
    Psychopharmacol Bull; 1984; 20(2):240-9. PubMed ID: 6374720
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative study of bupropion and amitriptyline in depressed outpatients.
    Mendels J; Amin MM; Chouinard G; Cooper AJ; Miles JE; Remick RA; Saxena B; Secunda SK; Singh AN
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):118-20. PubMed ID: 6406439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amoxapine and amitriptyline. II. Specificity of cognitive effects during brief treatment of depression.
    McNair DM; Kahn RJ; Frankenthaler LM; Faldetta LL
    Psychopharmacology (Berl); 1984; 83(2):134-9. PubMed ID: 6431462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical appraisal of amoxapine.
    Smith RS; Ayd FJ
    J Clin Psychiatry; 1981 Jun; 42(6):238-42. PubMed ID: 7240104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amoxapine: a review of its pharmacology and efficacy in depressed states.
    Jue SG; Dawson GW; Brogden RN
    Drugs; 1982 Jul; 24(1):1-23. PubMed ID: 7049659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind comparison of bupropion and amitriptyline in depressed inpatients.
    Davidson J; Miller R; Van Wyck Fleet J; Strickland R; Manberg P; Allen S; Parrott R
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):115-7. PubMed ID: 6406438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amoxapine--an antidepressant with some neuroleptic properties? A review of its chemistry, animal pharmacology and toxicology, human pharmacology, and clinical efficacy.
    Lydiard RB; Gelenberg AJ
    Pharmacotherapy; 1981; 1(3):163-78. PubMed ID: 6152816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of amoxapine in psychotic depression.
    Anton RF; Sexauer JD
    Am J Psychiatry; 1983 Oct; 140(10):1344-7. PubMed ID: 6624968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Speed of onset of action of the newer antidepressants.
    Lydiard RB; Pottash AL; Gold MS
    Psychopharmacol Bull; 1984; 20(2):258-71. PubMed ID: 6374722
    [No Abstract]   [Full Text] [Related]  

  • 38. Amoxapine for the treatment of psychotically depressed subjects. A pilot study.
    Falk WE; Gelenberg AJ; Wojcik JD
    J Nerv Ment Dis; 1985 Feb; 173(2):90-3. PubMed ID: 3968551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of amoxapine, a new antidepressant, on pseudoneurotic schizophrenia.
    Aono T; Kaneko M; Numata Y; Takahashi Y; Yamamoto T; Kumashiro H
    Folia Psychiatr Neurol Jpn; 1981; 35(2):115-21. PubMed ID: 7026396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients.
    Kayser A; Robinson DS; Yingling K; Howard DB; Corcella J; Laux D
    J Clin Psychopharmacol; 1988 Aug; 8(4):246-53. PubMed ID: 3062042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.